Rockefeller researchers have discovered that the antioxidant glutathione, acting within mitochondria, plays a crucial role in allowing breast tumors to spread to the lung. Mitochondria are best known as the cell’s powerhouse, but growing Read More
Tags :Oncology
Neutrophil-specific targeting of STAT3 impairs tumor progression via the expansion
Neutrophil-specific targeting of STAT3 impairs tumor progression via the expansion of cytotoxic CD8+ T cells Summary Targeting STAT3 specifically in neutrophils, a type of white blood cell, significantly hinders tumor progression, according to this research. Read More
Dementia-Like Behavior Discovered in Pre-Cancerous Cells – New Study/Science Updates
Scientists have found that precancerous pancreas cells may behave like dementia-affected brain cells, forming toxic protein clumps when their recycling system falters. Scientists have identified dementia-like activity in pancreatic cells that are at risk of Read More
Restricted blood flow speeds tumor growth by aging the immune system. The findings highlight risks for patients with vascular disease and potential new therapies. A new study from NYU Langone Health reports that restricted blood Read More
Ultrasound-enhanced Pt-coordinated polymer immunopotentiators and heterogenic fusion membrane-based multifunctional tumor
Ultrasound-enhanced Pt-coordinated polymer immunopotentiators and heterogenic fusion membrane-based multifunctional tumor vaccine nanoplatforms for melanoma treatment Summary This research explores a novel approach to melanoma treatment combining ultrasound-enhanced immunopotentiators and a multifunctional tumor vaccine nanoplatform. The Read More
Restoring cellular memory blocks cancer cells from adapting to escape treatment. Northwestern University biomedical engineers have developed a completely new approach to cancer therapy that doubled the effectiveness of chemotherapy in animal studies. Rather than Read More
Personalized circulating tumor DNA dynamics inform survival and response to
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer Summary This study investigates the utility of personalized circulating tumor DNA (ctDNA) monitoring in patients Read More
Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy
Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy Summary This research investigates the relationship between a “metabolic-immune score” and outcomes in advanced Non-Small Cell Lung Cancer (NSCLC) patients treated with immunotherapy. The score Read More
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system Summary GD2 ganglioside, highly expressed in several pediatric central nervous system (CNS) tumors like neuroblastoma and medulloblastoma, presents Read More
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma Summary Daratumumab refractoriness significantly worsens outcomes after CAR T-cell therapy in patients with relapsed/refractory multiple myeloma. Studies show Read More







